- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/20 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 233/20
Total number of patents in this class: 48
10-year publication summary
|
3
|
7
|
4
|
3
|
3
|
3
|
2
|
1
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| University of Florida Research Foundation, Inc. | 4154 |
5 |
| Centre National de La Recherche Scientifique | 10895 |
2 |
| Massachusetts Institute of Technology | 10209 |
2 |
| Board of Regents, The University of Texas System | 6062 |
2 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2261 |
2 |
| Assistance Publique - Hopitaux de Paris | 1031 |
2 |
| China University of Geosciences, Beijing | 78 |
2 |
| Gilead Sciences, Inc. | 2190 |
2 |
| University College Dublin, National University of Ireland, Dublin | 357 |
2 |
| F. Hoffmann-La Roche AG | 7841 |
1 |
| Janssen Pharmaceutica N.V. | 3226 |
1 |
| Toshiba Corporation | 12694 |
1 |
| Sumitomo Chemical Company, Limited | 9013 |
1 |
| The Johns Hopkins University | 5829 |
1 |
| Toray Industries, Inc. | 7053 |
1 |
| Henkel AG & Co. KGaA | 10702 |
1 |
| Cellixbio Private Limited | 144 |
1 |
| East China University of Science and Technology | 544 |
1 |
| Georgia State University Research Foundation, Inc. | 354 |
1 |
| Imprimis Pharmaceuticals, Inc. | 12 |
1 |
| Other owners | 16 |